Sex-related differences in antidepressant response: When to adjust treatment
Current Psychiatry. 2010 May;09(05):25-30
May 1, 2010|Current Psychiatry
Author and Disclosure Information
How pharmacodynamic, pharmacokinetic, and hormonal factors impact prescribing
Related resources
- Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry. 1998;44(9):839-850.
- Cohen LS, Nonacs RM, eds. Mood and anxiety disorders during pregnancy and postpartum. Arlington, VA: American Psychiatric Publishing, Inc.; 2005.
- Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 2000;157(9):1445-1452.
Drug brand names
- Bupropion • Wellbutrin
- Citalopram • Celexa
- Clomipramine • Anafranil
- Duloxetine • Cymbalta
- Escitalopram • Lexapro
- Estradiol • Estrace, Climara, others
- Fluoxetine • Prozac
- Fluvoxamine • Luvox
- Imipramine • Tofranil
- Mirtazapine • Remeron
- Nefazodone • Serzone
- Nortriptyline • Pamelor
- Sertraline • Zoloft
- Venlafaxine • Effexor
Disclosures
Dr. Marsh receives grant/research support from the University of Massachusetts.
Dr. Deligiannidis receives grant/research support from the Worcester Foundation for Biomedical Research and Forest Research Institute.
Acknowledgement
Dr. Deligiannidis’ contribution to this article was supported by the University of Massachusetts Medical School Department of Psychiatry and the University of Massachusetts Medical School Center for Psychopharmacologic Research and Treatment.
